Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patients

Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures need evaluation in the context of early compared with late metastatic risk prediction. In pre-clinical studies, we and others have shown tha...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical Society transactions Vol. 42; no. 6; p. 1498
Main Authors: Weitsman, Gregory, Lawler, Katherine, Kelleher, Muireann T, Barrett, James E, Barber, Paul R, Shamil, Eamon, Festy, Frederic, Patel, Gargi, Fruhwirth, Gilbert O, Huang, Lufei, Tullis, Iain D C, Woodman, Natalie, Ofo, Enyinnaya, Ameer-Beg, Simon M, Irshad, Sheeba, Condeelis, John, Gillett, Cheryl E, Ellis, Paul A, Vojnovic, Borivoj, Coolen, Anthony C C, Ng, Tony
Format: Journal Article
Language:English
Published: England 01.12.2014
Subjects:
ISSN:1470-8752, 1470-8752
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures need evaluation in the context of early compared with late metastatic risk prediction. In pre-clinical studies, we and others have shown that various protein-protein interactions, pertaining to the actin microfilament-associated proteins, ezrin and cofilin, mediate breast cancer cell migration, a prerequisite for cancer metastasis. Moreover, as a direct substrate for protein kinase Cα, ezrin has been shown to be a determinant of cancer metastasis for a variety of tumour types, besides breast cancer; and has been described as a pivotal regulator of metastasis by linking the plasma membrane to the actin cytoskeleton. In the present article, we demonstrate that our tissue imaging-derived parameters that pertain to or are a consequence of the PKC-ezrin interaction can be used for breast cancer prognostication, with inter-cohort reproducibility. The application of fluorescence lifetime imaging microscopy (FLIM) in formalin-fixed paraffin-embedded patient samples to probe protein proximity within the typically <10 nm range to address the oncological challenge of tumour heterogeneity, is discussed.
AbstractList Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures need evaluation in the context of early compared with late metastatic risk prediction. In pre-clinical studies, we and others have shown that various protein-protein interactions, pertaining to the actin microfilament-associated proteins, ezrin and cofilin, mediate breast cancer cell migration, a prerequisite for cancer metastasis. Moreover, as a direct substrate for protein kinase Cα, ezrin has been shown to be a determinant of cancer metastasis for a variety of tumour types, besides breast cancer; and has been described as a pivotal regulator of metastasis by linking the plasma membrane to the actin cytoskeleton. In the present article, we demonstrate that our tissue imaging-derived parameters that pertain to or are a consequence of the PKC-ezrin interaction can be used for breast cancer prognostication, with inter-cohort reproducibility. The application of fluorescence lifetime imaging microscopy (FLIM) in formalin-fixed paraffin-embedded patient samples to probe protein proximity within the typically <10 nm range to address the oncological challenge of tumour heterogeneity, is discussed.Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures need evaluation in the context of early compared with late metastatic risk prediction. In pre-clinical studies, we and others have shown that various protein-protein interactions, pertaining to the actin microfilament-associated proteins, ezrin and cofilin, mediate breast cancer cell migration, a prerequisite for cancer metastasis. Moreover, as a direct substrate for protein kinase Cα, ezrin has been shown to be a determinant of cancer metastasis for a variety of tumour types, besides breast cancer; and has been described as a pivotal regulator of metastasis by linking the plasma membrane to the actin cytoskeleton. In the present article, we demonstrate that our tissue imaging-derived parameters that pertain to or are a consequence of the PKC-ezrin interaction can be used for breast cancer prognostication, with inter-cohort reproducibility. The application of fluorescence lifetime imaging microscopy (FLIM) in formalin-fixed paraffin-embedded patient samples to probe protein proximity within the typically <10 nm range to address the oncological challenge of tumour heterogeneity, is discussed.
Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures need evaluation in the context of early compared with late metastatic risk prediction. In pre-clinical studies, we and others have shown that various protein-protein interactions, pertaining to the actin microfilament-associated proteins, ezrin and cofilin, mediate breast cancer cell migration, a prerequisite for cancer metastasis. Moreover, as a direct substrate for protein kinase Cα, ezrin has been shown to be a determinant of cancer metastasis for a variety of tumour types, besides breast cancer; and has been described as a pivotal regulator of metastasis by linking the plasma membrane to the actin cytoskeleton. In the present article, we demonstrate that our tissue imaging-derived parameters that pertain to or are a consequence of the PKC-ezrin interaction can be used for breast cancer prognostication, with inter-cohort reproducibility. The application of fluorescence lifetime imaging microscopy (FLIM) in formalin-fixed paraffin-embedded patient samples to probe protein proximity within the typically <10 nm range to address the oncological challenge of tumour heterogeneity, is discussed.
Author Gillett, Cheryl E
Huang, Lufei
Lawler, Katherine
Coolen, Anthony C C
Patel, Gargi
Fruhwirth, Gilbert O
Barrett, James E
Woodman, Natalie
Irshad, Sheeba
Ellis, Paul A
Condeelis, John
Ng, Tony
Weitsman, Gregory
Barber, Paul R
Shamil, Eamon
Ofo, Enyinnaya
Vojnovic, Borivoj
Ameer-Beg, Simon M
Festy, Frederic
Tullis, Iain D C
Kelleher, Muireann T
Author_xml – sequence: 1
  givenname: Gregory
  surname: Weitsman
  fullname: Weitsman, Gregory
  organization: Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K
– sequence: 2
  givenname: Katherine
  surname: Lawler
  fullname: Lawler, Katherine
– sequence: 3
  givenname: Muireann T
  surname: Kelleher
  fullname: Kelleher, Muireann T
– sequence: 4
  givenname: James E
  surname: Barrett
  fullname: Barrett, James E
  organization: †Department of Mathematics, King's College London, Strand Campus, London WC2R 2LS, U.K
– sequence: 5
  givenname: Paul R
  surname: Barber
  fullname: Barber, Paul R
  organization: §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K
– sequence: 6
  givenname: Eamon
  surname: Shamil
  fullname: Shamil, Eamon
  organization: Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K
– sequence: 7
  givenname: Frederic
  surname: Festy
  fullname: Festy, Frederic
  organization: ║Biomaterials, Biomimetics and Biophotonics Division, King's College London Dental Institute, London SE1 9RT, U.K
– sequence: 8
  givenname: Gargi
  surname: Patel
  fullname: Patel, Gargi
– sequence: 9
  givenname: Gilbert O
  surname: Fruhwirth
  fullname: Fruhwirth, Gilbert O
– sequence: 10
  givenname: Lufei
  surname: Huang
  fullname: Huang, Lufei
  organization: §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K
– sequence: 11
  givenname: Iain D C
  surname: Tullis
  fullname: Tullis, Iain D C
  organization: §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K
– sequence: 12
  givenname: Natalie
  surname: Woodman
  fullname: Woodman, Natalie
  organization: ††Guy's & St. Thomas' Breast Tissue & Data Bank, King's College London, Guy's Hospital, London SE1 9RT, U.K
– sequence: 13
  givenname: Enyinnaya
  surname: Ofo
  fullname: Ofo, Enyinnaya
  organization: Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K
– sequence: 14
  givenname: Simon M
  surname: Ameer-Beg
  fullname: Ameer-Beg, Simon M
  organization: Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K
– sequence: 15
  givenname: Sheeba
  surname: Irshad
  fullname: Irshad, Sheeba
  organization: ‡‡Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital King's College London School of Medicine, London, SE1 9RT, U.K
– sequence: 16
  givenname: John
  surname: Condeelis
  fullname: Condeelis, John
  organization: §§Tumor Microenvironment and Metastasis Program, Albert Einstein Cancer Center, New York, NY 10461, U.S.A
– sequence: 17
  givenname: Cheryl E
  surname: Gillett
  fullname: Gillett, Cheryl E
  organization: ††Guy's & St. Thomas' Breast Tissue & Data Bank, King's College London, Guy's Hospital, London SE1 9RT, U.K
– sequence: 18
  givenname: Paul A
  surname: Ellis
  fullname: Ellis, Paul A
  organization: ¶Department of Medical Oncology, Guy's and St. Thomas Foundation Trust, London SE1 9RT, U.K
– sequence: 19
  givenname: Borivoj
  surname: Vojnovic
  fullname: Vojnovic, Borivoj
– sequence: 20
  givenname: Anthony C C
  surname: Coolen
  fullname: Coolen, Anthony C C
  organization: †Department of Mathematics, King's College London, Strand Campus, London WC2R 2LS, U.K
– sequence: 21
  givenname: Tony
  surname: Ng
  fullname: Ng, Tony
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25399560$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OwzAQhC1UREvhxB35yCWw_k16hIqfikogUc6V42zaQGMX2zn0sXgRnokgisRpR6tvRrN7TAbOOyTkjMElA8mvbl4WHJgEptUBGTGZQ1bkig_-6SE5jvENeopJfUSGXInJRGkYkfdZa1aNW9HUtb4LdI0Jg1-hwybtqK9pWiO13kX86NBZjD87Q58fp1-fWezKmIJJSBvX24xNjXe9pmVAExO1pncEujWpQZfiCTmszSbi6X6Oyevd7WL6kM2f7mfT63lmBWMp01VdC8O4tBUUoi6YgVJxhgpAiFIWptTCFkrW_XmVqKGUBqQstFEVwMRqPiYXv7nb4PvWMS3bJlrcbIxD38Ul0zyHXOu86NHzPdqVLVbLbWhaE3bLvwfxb0UMakU
CitedBy_id crossref_primary_10_1109_JSTQE_2018_2889429
crossref_primary_10_1242_jcs_183129
crossref_primary_10_1016_j_gpb_2019_11_012
crossref_primary_10_1038_srep37874
crossref_primary_10_1186_s13058_015_0561_8
crossref_primary_10_1093_jbmrpl_ziae041
crossref_primary_10_1093_jnci_djz231
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1042/BST20140165
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1470-8752
ExternalDocumentID 25399560
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA164468
– fundername: Cancer Research UK
  grantid: C133/A/1812
– fundername: NCI NIH HHS
  grantid: R01 CA164468
– fundername: Cancer Research UK
  grantid: C1519/A10331
– fundername: NCI NIH HHS
  grantid: P01 CA100324
– fundername: NCI NIH HHS
  grantid: CA100324
– fundername: Cancer Research UK
  grantid: 16463
– fundername: Cancer Research UK
  grantid: 15677
– fundername: Cancer Research UK
  grantid: C1519/A16463
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
23N
2WC
3O-
4.4
53G
5GY
5RE
6J9
A8Z
AABGO
AAHRG
AAKDD
ABEFU
ABJNI
ACGFO
ACGFS
ACNCT
AEGXH
AENEX
AFFNX
AFHIN
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
C1A
CGR
CS3
CUY
CVF
DU5
E3Z
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
H13
HZ~
IH2
ML-
MV1
MVM
NPM
NTEUP
O9-
OHT
P2P
RHI
RNS
RPO
SV3
TWZ
UBE
VH1
X7M
XOL
ZGI
ZXP
ZY4
~02
~KM
7X8
ABUFD
ESTFP
ID FETCH-LOGICAL-c311t-6dff3a124cd083f81a0b521e50033b48ab63c854f147d3f0b4a04486a5d009c62
IEDL.DBID 7X8
ISICitedReferencesCount 7
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000345427100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1470-8752
IngestDate Sun Nov 09 13:59:19 EST 2025
Sat May 31 02:10:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c311t-6dff3a124cd083f81a0b521e50033b48ab63c854f147d3f0b4a04486a5d009c62
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://doi.org/10.1042/BST20140165
PMID 25399560
PQID 1627076678
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1627076678
pubmed_primary_25399560
PublicationCentury 2000
PublicationDate 2014-Dec
20141201
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-Dec
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biochemical Society transactions
PublicationTitleAlternate Biochem Soc Trans
PublicationYear 2014
SSID ssj0014146
Score 2.1494484
SecondaryResourceType review_article
Snippet Breast cancer heterogeneity demands that prognostic models must be biologically driven and recent clinical evidence indicates that future prognostic signatures...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1498
SubjectTerms Actin Depolymerizing Factors - metabolism
Breast Neoplasms - enzymology
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cytoskeletal Proteins - metabolism
Female
Fluorescence Resonance Energy Transfer
Humans
Neoplasm Metastasis
Phosphorylation
Protein Kinase C-alpha - metabolism
Subcellular Fractions - metabolism
Substrate Specificity
Treatment Outcome
Title Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patients
URI https://www.ncbi.nlm.nih.gov/pubmed/25399560
https://www.proquest.com/docview/1627076678
Volume 42
WOSCitedRecordID wos000345427100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qFH3xsnmZNyKIb2HpJU37JNtwKOIYOGFvI0kbFFk7103wZ_lH_E2epC3zRRB8KaE0pZyenHzn5JzzIXRJpelSFvkkoKFPAIEzEsYRJ0qzyFVKSqF9SzbB-_1wNIoGZcAtL9MqK5toDXWcKRMjbzmBy8HnBtt6PX0jhjXKnK6WFBqrqOYBlDFazUfLUwS_qi7iFFY9c8v6PNDTVudx6FrnImC_Y0u7x_R2_vt1u2i7RJe4XajDHlpJ0jpqtFPwrCcf-ArbfE8bSK-jjU412uxWrG8N9Ho3sbxFeL6YwNvws0mXyUDLEoDrONMYACNWP1KwzT2BB_fdr0-SgxWy3W6x6UIxK2omYIylSX2fY2VUbIbLXq75Pnrq3Qy7t6QkZCDKc5w5CWKtPQGIQMWA3HToCCph-0-YYYSTfihk4KmQ-RokHnuaSl9QcP8CwWKAcipwD9BamqXJEcJM8lBQTWnC4WEdCpcnMBO8NeUIn0dNdFEJegwSMKcYIk2yRT5eirqJDou_NZ4WnTnGLrOVuvT4D7NP0JbRgCI15RTVNCz35Aytq_f5Sz47t5oE1_7g4RuniNPB
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imaging+tumour+heterogeneity+of+the+consequences+of+a+PKC%CE%B1-substrate+interaction+in+breast+cancer+patients&rft.jtitle=Biochemical+Society+transactions&rft.au=Weitsman%2C+Gregory&rft.au=Lawler%2C+Katherine&rft.au=Kelleher%2C+Muireann+T&rft.au=Barrett%2C+James+E&rft.date=2014-12-01&rft.eissn=1470-8752&rft.volume=42&rft.issue=6&rft.spage=1498&rft_id=info:doi/10.1042%2FBST20140165&rft_id=info%3Apmid%2F25399560&rft_id=info%3Apmid%2F25399560&rft.externalDocID=25399560
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-8752&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-8752&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-8752&client=summon